ema glp-1 vision loss recommendation october 2025 Indiana woman reports after taking drug; scientific research suggests drugs potentially increase risk for 'eye stroke' GLP-1 Drugs and Ocular Disease:

It is an exciting time for patients and providers alike, and I am hopeful these advances will continue to improve access, affordability, and long-term outcomes

Gastrointestinal (GI) side effects are common in people with diabetes treated both with metformin and with GLP-1 receptor agonists (GLP-1RAs), and they

Compounded tirzepatide requires careful storage to maintain its potency

From 2016 through 2022, the utilization of transitional assistance has steadily increased from 41% to 56% of all commercial claims

Beyond their roles in diabetes treatment, AGIs have shown potential in extending lifespan and effectively treating aging-related diseases by modulating oxidative stress, gut microbiota, inflammatory responses, and nutrient-sensing pathways

Complete your weight loss journey with LiftEX